Skip to Main Content

Author Details

Travis R Taylor
University of Toledo
2002
50
23
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
33884670Xenotransplantation Literature Update January/February 2021.Xenotransplantation2021
35574425A Multi-Disciplinary Review on the Aerobiology of COVID-19 in Dental Settings.Front Dent Med2021
33627767Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach.Sci Rep2021
32404065Intrathecal blood injection: a case report of a rare complication of an epidural blood patch.BMC Neurol2020
32702077Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS.Res Sq2020
32697003Human anti-α-fucose antibodies are xenoreactive toward GGTA1/CMAH knockout pigs.Xenotransplantation2020
32273341The interferon-inducible protein TDRD7 inhibits AMP-activated protein kinase and thereby restricts autophagy-independent virus replication.J Biol Chem2020
31129244TRAF6 Plays a Proviral Role in Tick-Borne Flavivirus Infection through Interaction with the NS3 Protease.iScience2019
29427359Xenotransplantation literature update, November/December 2017.Xenotransplantation2018
29913038Xenotransplantation literature update, March/April 2018.Xenotransplantation2018
30536839Xenotransplantation literature update, September/October 2018.Xenotransplantation2018
28880960Correction: Correction: A Novel Rhabdovirus Associated with Acute Hemorrhagic Fever in Central Africa.PLoS Pathog2017
34595308Lentiviral Knockdown of Transcription Factor STAT1 in <i>Peromyscus leucopus</i> to Assess Its Role in the Restriction of Tick-borne Flaviviruses.Bio Protoc2017
28650973Interferon signaling in Peromyscus leucopus confers a potent and specific restriction to vector-borne flaviviruses.PLoS One2017
26991269Correction: A Novel Rhabdovirus Associated with Acute Hemorrhagic Fever in Central Africa.PLoS Pathog2016
27511894Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga.J Infect Dis2016
25988427Xenotransplantation literature update, March-April 2015.Xenotransplantation2015
26669726Xenotransplantation literature update, September-October 2015.Xenotransplantation2015
26159719Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression.Cell Host Microbe2015
24894205Xenotransplantation literature update, March-April 2014.Xenotransplantation2014
25462446RNA replication errors and the evolution of virus pathogenicity and virulence.Curr Opin Virol2014
25250866Xenotransplantation literature update, July-August 2014.Xenotransplantation2014
23136362Toll-like receptor 7 suppresses virus replication in neurons but does not affect viral pathogenesis in a mouse model of Langat virus infection.J Gen Virol2013
24146620Ebola virus RNA editing depends on the primary editing site sequence and an upstream secondary structure.PLoS Pathog2013
23554892Identification of a novel human papillomavirus by metagenomic analysis of samples from patients with febrile respiratory illness.PLoS One2013
23028323A novel rhabdovirus associated with acute hemorrhagic fever in central Africa.PLoS Pathog2012
21925107TRIM79α, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase.Cell Host Microbe2011
21855635Assessing ubiquitination of viral proteins: Lessons from flavivirus NS5.Methods2011
20668102Genetic variants of human organic anion transporter 4 demonstrate altered transport of endogenous substrates.Am J Physiol Renal Physiol2010
18841330Tick-borne flaviviruses: dissecting host immune responses and virus countermeasures.Immunol Res2009
18364470The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene.J Pharmacol Exp Ther2008
17700366Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4).Pharmacogenet Genomics2007
16291576The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics.Am J Physiol Renal Physiol2006
17041226Human cytomegalovirus IE86 attenuates virus- and tumor necrosis factor alpha-induced NFkappaB-dependent gene expression.J Virol2006
16702441Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants.J Pharmacol Exp Ther2006
16931768Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).Mol Pharmacol2006
16507879PharmGKB submission update: VI. PMT submissions of genetic variations in neurotransmitter transporters (SLC6, SLC17, and SLC18) to the PharmGKB network.Pharmacol Rev2006
16507878PharmGKB submission update: V. PMT submissions of genetic variation in SLC22 family transporters.Pharmacol Rev2006
16507877PharmGKB submission update: IV. PMT submissions of genetic variations in ATP-Binding cassette transporters to the PharmGKB network.Pharmacol Rev2006
16214850Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2.Drug Metab Dispos2006
16378994Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression.J Virol2006
15728525Effect of human cytomegalovirus on expression of MHC class I-related chains A.J Immunol2005
16337902Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11-16.Neuron2005
15864112Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1).Pharmacogenet Genomics2005
15861032Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2.Pharmacogenet Genomics2005
15731283Human cytomegalovirus immediate-early 2 gene expression blocks virus-induced beta interferon production.J Virol2005
12719533Natural variation in human membrane transporter genes reveals evolutionary and functional constraints.Proc Natl Acad Sci U S A2003
12893986Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene.Pharmacogenetics2003
12869664PharmGKB update: I. Genetic variants of the organic cation transporter 2 (OCT2, SLC22A2).Pharmacol Rev2003
12142729Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function.Pharmacogenetics2002
  • 1 - 50 of 50

Recommended Authors

Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 0
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 0
Boston University Chobanian and Avedisian School of Medicine
Career Start Year 2007
Number of shared co-authors 0
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Career Start Year 2006
Number of shared co-authors 0
Lankenau Institute for Medical Research
Career Start Year 2004
Number of shared co-authors 2
Minnesota Supercomputing Institute, University of Minnesota
Career Start Year 2003
Number of shared co-authors 1
Stanford University School of Medicine
Career Start Year 2002
Number of shared co-authors 0
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2001
Number of shared co-authors 0
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 2
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 0
Pondicherry University
Career Start Year 1997
Number of shared co-authors 0
Center for Global Infectious Disease Research, Seattle Children's Hospital
Career Start Year 1997
Number of shared co-authors 1
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1997
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 1
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 1994
Number of shared co-authors 1
Gladstone Institute of Virology
Career Start Year 1993
Number of shared co-authors 2
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1992
Number of shared co-authors 1
University of California los angeles
Career Start Year 1992
Number of shared co-authors 0
University of Western Ontario
Career Start Year 1992
Number of shared co-authors 0
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 2
McLean Hospital and Program in Neuroscience, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 0
Yale University
Career Start Year 1990
Number of shared co-authors 1
Merck & Co., Inc.
Career Start Year 1989
Number of shared co-authors 0
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1988
Number of shared co-authors 3
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 1
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 1
J. Craig Venter Institute
Career Start Year 1983
Number of shared co-authors 2
University of Texas Medical Branch
Career Start Year 1983
Number of shared co-authors 0
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 1

Collaborators

University of California San Francisco
Co-authored papers 16
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 16
Center for Visualization, Washington State University
Co-authored papers 15
University of California San Francisco
Co-authored papers 15
Co-authored papers 15
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 14
University of California san francisco
Co-authored papers 12
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 8
University of California San Francisco (UCSF)
Co-authored papers 7
University of California San Francisco
Co-authored papers 6
University of California san francisco
Co-authored papers 6
Eshelman School of Pharmacy, University of North Carolina
Co-authored papers 5
National Institute of Allergy and Infectious Diseases
Co-authored papers 4
University of California san francisco
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
National Institute of Biomedical Research (INRB)
Co-authored papers 3
National Institute of Allergy and Infectious Diseases
Co-authored papers 3
University of California-San Francisco
Co-authored papers 3
Rice University
Co-authored papers 3
Co-authored papers 2
Genentech Inc.
Co-authored papers 2
Co-authored papers 2
University of California San Francisco
Co-authored papers 1
University of California san francisco
Co-authored papers 1
University of Washington
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Department of Pharmacy, Ewha Womans University
Co-authored papers 1
National Institute of Allergy and Infectious Diseases
Co-authored papers 1
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 1